To evaluate an HRT clinic platform’s compounding pharmacy integration, check four things: which compounding pharmacies are actually connected, how prescriptions route to them, whether refills run automatically, and who owns the pharmacy relationship. That handoff decides whether patients receive medication on time and whether they stay with your brand.
Why HRT programs live or die at the pharmacy handoff
Hormone replacement therapy is a recurring-revenue business. The demand data explains why: researchers project that more than 1.2 billion women worldwide will be menopausal or postmenopausal by 2030, according to the 2023 Practitioner’s Toolkit for Managing Menopause published in Climacteric. The Menopause Society notes that hormone therapy is the treatment used most often for menopause symptoms, which makes compounded hormones one of the few cash-pay categories with a built-in base of patients already seeking it. An HRT program turns that demand into monthly recurring revenue because treatment is ongoing rather than episodic.
Here is where most programs quietly fail. After a provider approves a patient, the prescription has to travel from the platform to a compounding pharmacy, get compounded into the right formulation, and ship to the patient’s door. That chain contains four handoffs: prescription generation, pharmacy routing, compounding, and delivery. Every handoff is a chance for the patient to disappear.
The breaks are concrete. The pharmacy may not be licensed to ship to the patient’s state, which is a real constraint for 503A pharmacies that must be licensed state by state. The formulation a provider wants, such as a specific estradiol cream base, may not exist in the pharmacy’s catalog. Prescription details may be re-typed manually by pharmacy staff because the platform has no structured connection, which invites errors. And if refills require the patient to contact anyone, the patient treats the program as a monthly chore instead of a subscription.
The business cost is measurable. A patient who pays at signup and then waits two weeks for a first shipment is a patient who cancels, requests a refund, and posts a review. Retention drives the economics of an HRT program because patients who stay generate monthly revenue for years. The fill experience is the retention strategy, and it depends entirely on the pharmacy handoff. Platforms that treat that handoff as an afterthought leave you to absorb the risk. Platforms that own it remove it.
How to evaluate an HRT platform’s compounding pharmacy integration
The phrase “pharmacy integration” means different things on different platforms. On some, it means a fax number. On others, it means an API connection with structured orders and shipment tracking. Your job is to pin down which one you are buying by examining the platform’s actual connection, not its marketing page.
Which compounding pharmacies are actually connected
Ask for the list. In HRT telehealth, the pharmacies that come up in evaluation conversations are Olympia Pharmacy, Empower Pharmacy, Belmar Pharma Solutions, and Strive Pharmacy. Each routes prescriptions through its own portal: Olympia through DrScript, Empower through a catalog-style ordering system, Belmar through direct-to-processing order routing, and Strive through its own ordering workflow. A platform connected to one pharmacy through one portal is a different proposition from a platform that maintains active connections to several. Count the connections, and ask which states each one covers.
503A or 503B, and what that means for coverage
503A pharmacies compound patient-specific prescriptions and must be licensed in each state where they ship. 503B outsourcing facilities compound in advance under FDA oversight and can distribute across state lines. The difference matters for telehealth: a 503B partner simplifies multi-state coverage, while a 503A-only setup leaves gaps in any state where the pharmacy is not licensed. The FDA’s list of registered outsourcing facilities showed 98 facilities as of August 2026, so a platform claiming broad 503B coverage can be checked against a public list. Our 503A vs 503B pharmacy guide walks through the licensing trade-offs in detail.
How prescriptions route
The second question is mechanical: does the prescription move as structured data or as a manual process? Structured e-prescribing drops the order into the pharmacy’s system with the patient’s name, the formulation, the dose, and the directions already populated. Manual routing means someone re-keys the order, which is where errors and delays come from. Controlled substances raise the bar. Testosterone is a Schedule III substance, so electronic prescribing requires EPCS with two-factor authentication under DEA rules. If a platform cannot demonstrate EPCS, testosterone orders fall back to paper, fax, or phone.
How refills work
Ask what happens when a patient runs out. The cleanest model is a prescription that covers a defined period with automatic refills, so the patient receives the next shipment without initiating anything. In Karpa’s model, a prescription covers six months with automatic refills, and a new provider review is required before the next prescription is issued. The alternative is a refill process that requires the patient or your staff to ask, which is where retention leaks.
Who owns the pharmacy relationship
Finally, determine who holds the contracts. If the platform owns the pharmacy relationships, it absorbs the operational burden of pharmacy outages, license changes, and formulation updates, and you are protected from single-pharmacy risk. If you are expected to bring your own pharmacy contracts, you control the formulary and the margin, but you also carry the compliance and operations work. Our guide to choosing a compounding pharmacy partner covers what that relationship entails when you own it.
LifeFile, OptiMantra, Cerbo, and Charm: what to check about each
The platforms people most often compare for HRT clinics are LifeFile, OptiMantra, Cerbo, and CharmHealth. They are not equivalent, and none of them is a complete program platform. Each solves part of the chain, and each has a specific pharmacy-integration question attached to it.
LifeFile (ePowerRx)
LifeFile’s ePowerRx is an e-prescribing network built around compounding pharmacies. It gives clinics a catalog-based ordering workflow with saved favorites and practice-customized formularies, and it is the network many compounding pharmacies accept orders through. If your clinic software routes prescriptions through LifeFile, the question to ask is which pharmacies in the network your platform has active connections with, whether the network covers every state you serve, and whether EPCS is available for testosterone.
OptiMantra
OptiMantra is an EMR and practice management platform popular with integrative and aesthetic clinics. It handles charting, scheduling, and standard e-prescribing, and its pricing is transparent. The evaluation question is whether its e-prescribing reaches compounding pharmacies at all. Standard e-prescribing routes ordinary prescriptions, but compounded HRT formulations with custom bases and strengths sit outside the standard pharmacy network. Check whether a compounded order moves electronically or becomes a manual step for your staff.
Cerbo
Cerbo is a cloud EHR designed for independent practices, with strong charting and medication workflow tools. It is not a compounding network. If your pharmacy partner accepts standard e-prescribing, Cerbo can route simple orders, but compounded formulations typically require the pharmacy’s own portal or an e-prescribing network like LifeFile. Ask how your providers would actually get an estradiol cream order into the pharmacy’s system, and whether that path is electronic or manual.
CharmHealth
CharmHealth is an AI-powered EHR that combines charting, billing, and patient engagement for practices. The pharmacy question is the same: which compounding pharmacies does its routing reach, and does it handle multi-state coverage? A general EHR can chart your HRT patients cleanly while the prescription handoff still runs on fax. Confirm the actual path before you assume integration exists.
The pattern behind all four
Each of these tools answers the charting question: where the clinical record lives and how the provider documents. None of them answers the business questions that decide whether an HRT program is profitable. Those questions are who covers prescribing in states where your own providers are not licensed, whose brand the patient sees, who owns the patient relationship, and who runs the pharmacy operation. If you build your program on a charting tool, you are the one assembling the rest of the chain.
What a complete HRT platform provides
A complete platform is not a better charting tool. It is the rest of the chain, packaged so you do not assemble it yourself.
Provider coverage
Every prescription needs a licensed provider. A complete platform either works with the providers you bring or provides access to a provider network that covers all 50 states, so a patient in any state can be served even when your own providers are not licensed there. This is the piece that most often stops a clinic or brand from launching nationally, and it is covered in detail in our guide to launching an HRT telehealth brand.
White-label brand and patient ownership
Patients should see your brand through signup, communication, and delivery, and the patient relationship should belong to you. If a platform routes patients through its own brand or keeps the patient list, you have built a channel for someone else. Ownership of the patient is the asset that makes the program worth running.
Pharmacy operations
The platform should run the pharmacy operation: maintaining active connections to multiple compounding pharmacies, checking state coverage, handling license changes, and managing refill logic. When a pharmacy cannot serve a patient, the platform should route to another pharmacy without you intervening.
Compliance as a built-in feature
Compounded HRT sits in a regulated space: 503A and 503B rules, state pharmacy licensure, and controlled-substance prescribing for testosterone. A complete platform bakes these into the workflow so compliance is not a monthly project for your staff.
What it costs and what you keep
Pricing models vary more than features do. Karpa’s White Label and Full Telehealth tiers use a monthly platform fee with no per-patient fee, and you set your own patient pricing and keep the margin above medication and consult costs. That structure matters because it keeps patient ownership and revenue with you rather than converting you into a volume business for someone else’s platform.
Evaluation questions and red flags
Bring these questions to any demo:
- Which compounding pharmacies are connected today, and in which states can each one ship?
- Can I see a prescription route end to end, from provider approval to shipment confirmation, in the demo?
- How are refills triggered, and what does the patient have to do?
- What happens when a pharmacy is not licensed in a patient’s state?
- Who holds the pharmacy contracts, and what happens if a pharmacy stops serving your program?
- Is testosterone e-prescribed with EPCS, or does it fall back to manual methods?
- Whose brand appears on patient communications and packaging?
Then watch for red flags. A platform that says “we work with any pharmacy” but will not name its current connections is describing an aspiration, not an integration. Fax-based or manual routing is a red flag for a national program. A single-pharmacy integration is a concentration risk: if that pharmacy loses a license or stops serving your segment, the program stops. And a platform that expects you to maintain your own pharmacy contracts, provider coverage, and compliance monitoring is a charting tool with a sales page, one whose true cost shows up in staff hours spent on pharmacy calls, refill chases, and license checks. Most general EHRs look inexpensive at the monthly price and expensive once the operational work is counted.
If you would rather evaluate a platform that already owns the pharmacy handoff, Book a call with Karpa Health and we will walk you through the connections, the routing, and the state coverage before you pay for anything.
